Lista de obras -

8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

artículo científico publicado en 2019

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma

scientific article published on 12 October 2018

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

artículo científico publicado en 2019

Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer

artículo científico publicado en 2020

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma

artículo científico publicado en 2020

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

scientific article published on 19 November 2019

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

artículo científico publicado en 2016

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

artículo científico publicado en 2016

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

scientific article published on 02 August 2019

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

artículo científico publicado en 2017

High homogeneity of MMR deficiency in ovarian cancer

artículo científico publicado en 2020

High homogeneity of mismatch repair deficiency in advanced prostate cancer

scientific article published on 06 December 2019

High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma

artículo científico publicado en 2020

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

artículo científico publicado en 2017

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

artículo científico publicado en 2017

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

artículo científico publicado en 2019

Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas

scientific article published on 06 March 2020

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

artículo científico publicado en 2018

Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

artículo científico publicado en 2017

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

scientific article published on 01 May 2019

MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes

artículo científico publicado en 2020

MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass

scientific article published on 14 February 2020

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

artículo científico publicado en 2018

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

scientific article published on 24 December 2019

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

artículo científico publicado en 2017

Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

artículo científico publicado en 2020

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

scientific article published on 23 December 2019

Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck

artículo científico publicado en 2017

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

artículo científico publicado en 2019

Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer

artículo científico publicado en 2020

SNW1 is a prognostic biomarker in prostate cancer

scientific article published on 01 May 2019

The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

artículo científico publicado en 2019

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

scientific article published on 25 September 2019

Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers

scientific article published on 02 June 2020

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

artículo científico publicado en 2017

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

artículo científico publicado en 2016

Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

artículo científico publicado en 2020

Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer

scientific article published on 25 April 2020

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

artículo científico publicado en 2020

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

scientific article published on 06 March 2020

Lista de obras de

8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer

Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancer

Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma

Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

Deletion of 3p13 is a late event linked to progression of : fusion prostate cancer

Deletion of 8p is an independent prognostic parameter in prostate cancer

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

High homogeneity of MMR deficiency in ovarian cancer

High homogeneity of mismatch repair deficiency in advanced prostate cancer

High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma

High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas

Immunohistochemically detected IDH1R132H mutation is rare and mostly heterogeneous in prostate cancer

Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes

MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues

Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues

Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer

SNW1 is a prognostic biomarker in prostate cancer

The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion